| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lymphocytosis | D008218 | 2 associated lipids |
| Radicular Cyst | D011842 | 2 associated lipids |
| Gingival Recession | D005889 | 2 associated lipids |
| Carcinoma, Medullary | D018276 | 2 associated lipids |
| Foot Deformities, Acquired | D005531 | 2 associated lipids |
| Tooth Migration | D014085 | 2 associated lipids |
| Dengue | D003715 | 2 associated lipids |
| Musculoskeletal Diseases | D009140 | 2 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| No-Reflow Phenomenon | D054318 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Moran CS et al. | Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm. | 2010 | Clin. Endocrinol. (Oxf) | pmid:19438902 |
| Yilmaz Y et al. | Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20942739 |
| Kobayashi-Sakamoto M et al. | Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. | 2010 | Eur. J. Haematol. | pmid:20331738 |
| Lee HJ et al. | Heme oxygenase-1 protects human periodontal ligament cells against substance P-induced RANKL expression. | 2010 | J. Periodont. Res. | pmid:20337895 |
| Noheria A et al. | Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. | 2010 | Am. J. Hypertens. | pmid:20339356 |
| Mogi M and Kondo A | ELISA for RANKL-OPG complex in mouse sera. | 2010 | J Immunoassay Immunochem | pmid:20391022 |
| Schramm HM | The role of the osteoimmune axis in the inflammation of the inner auditory ear and with regard to the putative anticarcinogenetic principle: part 2. | 2010 | Inflamm Allergy Drug Targets | pmid:20402646 |
| Vik A et al. | Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study. | 2010 | J. Thromb. Haemost. | pmid:20738762 |
| Bartold PM et al. | Mechanisms and control of pathologic bone loss in periodontitis. | 2010 | Periodontol. 2000 | pmid:20403105 |
| Dalbeth N et al. | Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. | 2010 | Arthritis Res. Ther. | pmid:20796300 |
| Nannuru KC et al. | Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. | 2010 | Cancer Res. | pmid:20406980 |
| Cody JJ et al. | Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer. | 2010 | Cancer Gene Ther. | pmid:20798695 |
| Wu WT et al. | The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study. | 2010 | J Womens Health (Larchmt) | pmid:20210559 |
| Akat K et al. | Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. | 2010 | Am. J. Cardiol. | pmid:20211333 |
| Fanourakis G et al. | Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws. | 2010 | J. Oral Pathol. Med. | pmid:20701665 |
| Canon J et al. | Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis. | 2010 | Bone | pmid:20215062 |
| Verdrengh M et al. | RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. | 2010 | Bone | pmid:19879986 |
| Sanchez-Niño MD et al. | New paradigms in cell death in human diabetic nephropathy. | 2010 | Kidney Int. | pmid:20703212 |
| Kauther MD et al. | Biochemical markers of particle induced osteolysis in C57BL/6 mice. | 2010 | Clin. Chem. Lab. Med. | pmid:20704528 |
| Wagner D and Fahrleitner-Pammer A | Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? | 2010 | Wien Med Wochenschr | pmid:20714810 |
| Winzer M et al. | Glycitein decreases the generation of murine osteoclasts and increases apoptosis. | 2010 | Wien Med Wochenschr | pmid:20714813 |
| Gruber R | Cell biology of osteoimmunology. | 2010 | Wien Med Wochenschr | pmid:20714814 |
| Deng S et al. | Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis. | 2010 | Cell. Immunol. | pmid:20716449 |
| Ochi H et al. | The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. | 2010 | J. Orthop. Res. | pmid:19890995 |
| Jensen JK et al. | Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. | 2010 | J. Intern. Med. | pmid:19895657 |
| Zupan J et al. | Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women. | 2010 | J. Steroid Biochem. Mol. Biol. | pmid:19896533 |
| Le Heron L et al. | Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. | 2010 | J. Cyst. Fibros. | pmid:20005786 |
| Jules J et al. | Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. | 2010 | Expert Opin. Ther. Targets | pmid:20678025 |
| Shead EF et al. | Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. | 2010 | J. Cyst. Fibros. | pmid:20006563 |
| Fong JE et al. | Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase. | 2010 | J. Biol. Chem. | pmid:20679341 |
| Kim M et al. | Td92, an outer membrane protein of Treponema denticola, induces osteoclastogenesis via prostaglandin E(2)-mediated RANKL/osteoprotegerin regulation. | 2010 | J. Periodont. Res. | pmid:20682013 |
| Lossdörfer S et al. | Aging affects the phenotypic characteristics of human periodontal ligament cells and the cellular response to hormonal stimulation in vitro. | 2010 | J. Periodont. Res. | pmid:20682014 |
| Jang S et al. | Wogonin inhibits osteoclast formation induced by lipopolysaccharide. | 2010 | Phytother Res | pmid:19998398 |
| Sanuki R et al. | Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells. | 2010 | Connect. Tissue Res. | pmid:20001844 |
| Ostrowski MC | A new role for OPG: putting RANKL in its place. | 2010 | J. Bone Miner. Res. | pmid:20684024 |
| Ikeda K et al. | [Animal models for vascular calcification]. | 2010 | Clin Calcium | pmid:21037386 |
| Cawley NX et al. | Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. | 2010 | Am. J. Physiol. Endocrinol. Metab. | pmid:20460579 |
| Jiang R et al. | High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. | 2010 | Int. J. Cancer | pmid:19728335 |
| Rhee EJ et al. | The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women. | 2010 | Endocr. J. | pmid:20431232 |
| Wiwanitkit V | Osteoprotegerin and acute ischaemic stroke. | 2010 | J. Intern. Med. | pmid:20433585 |
| Qian Y and Huang HZ | The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. | 2010 | J. Oral Pathol. Med. | pmid:20412401 |
| Qian H et al. | Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. | 2010 | J. Periodont. Res. | pmid:20412420 |
| Eagan TM et al. | Body composition and plasma levels of inflammatory biomarkers in COPD. | 2010 | Eur. Respir. J. | pmid:20413541 |
| Lamoureux F et al. | Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment. | 2010 | Biochim. Biophys. Acta | pmid:19733222 |
| Mine Y et al. | Impact of titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. | 2010 | J Prosthodont Res | pmid:19733525 |
| Xu DR et al. | [Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease]. | 2010 | Zhongguo Shi Yan Xue Ye Xue Za Zhi | pmid:20416172 |
| Hamed EA et al. | Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density. | 2010 | J. Pediatr. Hematol. Oncol. | pmid:20445416 |
| Gupta N et al. | IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. | 2010 | J. Immunol. | pmid:20644169 |
| Pedersen ER et al. | Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. | 2010 | Atherosclerosis | pmid:20621297 |
| Long L et al. | Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus. | 2010 | J. Clin. Immunol. | pmid:20589421 |
| Odiere MR et al. | Protein deficiency and nematode infection during pregnancy and lactation reduce maternal bone mineralization and neonatal linear growth in mice. | 2010 | J. Nutr. | pmid:20660285 |
| Saito-Yabe M et al. | PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver. | 2010 | J. Pharm. Pharmacol. | pmid:20663032 |
| Pantsulaia I et al. | Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. | 2010 | Osteoarthr. Cartil. | pmid:20633673 |
| Passeri G et al. | Adhesion pattern and growth of primary human osteoblastic cells on five commercially available titanium surfaces. | 2010 | Clin Oral Implants Res | pmid:20636730 |
| Zhu LL et al. | [Concentration measurement of the OPG and sRANKL of peripheral blood among normal healthy people]. | 2010 | Zhongguo Gu Shang | pmid:20345025 |
| Tenta R et al. | Osteoprotegerin and nuclear factor-kappaB ligand are associated with leptin and adiponectin levels, in apparently healthy women. | 2010 | J Musculoskelet Neuronal Interact | pmid:20516635 |
| Scott JP et al. | The effect of training status on the metabolic response of bone to an acute bout of exhaustive treadmill running. | 2010 | J. Clin. Endocrinol. Metab. | pmid:20519353 |
| Duan XH et al. | [The endocrine function of the skeleton]. | 2010 | Sheng Li Ke Xue Jin Zhan | pmid:21416939 |
| Komosińska-Vassev K et al. | [Osteoporosis--pathophysiology and laboratory diagnostic methods]. | 2010 | Prz. Lek. | pmid:21387765 |
| Zhang L et al. | Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. | 2010 | Gene Ther. | pmid:20428210 |
| Kim YG et al. | Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. | 2010 | Arthritis Rheum. | pmid:20112365 |
| Moreno-Rubio J et al. | Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis. | 2010 | Arthritis Rheum. | pmid:20112374 |
| Wagner H | Bone diseases: Interferon regulatory factor-8 suppresses osteoclastogenesis. | 2010 | Nat Rev Rheumatol | pmid:20125173 |
| Jiang XY et al. | Association of LPR5 polymorphism with bone mass density and cholesterol level in population of Chinese Han. | 2010 | Exp. Clin. Endocrinol. Diabetes | pmid:20146170 |
| Stankovic KM et al. | Differences in gene expression between the otic capsule and other bones. | 2010 | Hear. Res. | pmid:20146935 |
| Krause U et al. | Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20150512 |
| Daoussis D et al. | Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. | 2010 | Semin. Arthritis Rheum. | pmid:19095294 |
| Appel H et al. | Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis. | 2010 | J. Rheumatol. | pmid:20156950 |
| Zdzisińska B et al. | Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells. | 2010 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:20157786 |
| Xu Y et al. | Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. | 2010 | Planta Med. | pmid:20157877 |
| Ooi LL et al. | Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. | 2010 | Cancer Res. | pmid:20160035 |
| Dimitrow PP | Aortic valve stenosis as a complex inflammatory-hematological-osteogenic disease. | 2010 | Atherosclerosis | pmid:20864109 |
| Lee JE et al. | Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. | 2010 | Diabetes Res. Clin. Pract. | pmid:20092902 |
| Flyvbjerg A | Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. | 2010 | Nat Rev Endocrinol | pmid:20098449 |
| Scudla V et al. | The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma. | 2010 | Neoplasma | pmid:20099972 |
| Borsje MA et al. | Comparison of low-intensity pulsed ultrasound and pulsed electromagnetic field treatments on OPG and RANKL expression in human osteoblast-like cells. | 2010 | Angle Orthod | pmid:20050743 |
| Ruiz-Gaspà S et al. | Lithocholic acid downregulates vitamin D effects in human osteoblasts. | 2010 | Eur. J. Clin. Invest. | pmid:20055894 |
| Sypniewska G et al. | Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? | 2010 | Med. Sci. Monit. | pmid:20110921 |
| Elias LS et al. | Markers of bone remodeling in neoplastic and bone-related lesions. | 2010 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:20955951 |
| Nozaki K et al. | Effect of cyclic mechanical loading on osteoclast recruitment in periodontal tissue. | 2010 | J. Periodont. Res. | pmid:19602121 |
| Subramaniam M et al. | TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20059964 |
| O'Sullivan EP et al. | Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. | 2010 | Thromb. Res. | pmid:20932553 |
| Corallini F et al. | TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. | 2010 | Cell. Mol. Life Sci. | pmid:20063037 |
| Zhang YG et al. | Effect of negative pressure on human bone marrow mesenchymal stem cells in vitro. | 2010 | Connect. Tissue Res. | pmid:20067412 |
| Kokkotou E et al. | Serum correlates of the placebo effect in irritable bowel syndrome. | 2010 | Neurogastroenterol. Motil. | pmid:20028464 |
| Dereka XE et al. | RANKL and OPG mRNA level after non-surgical periodontal treatment. | 2010 | Inflammation | pmid:20033478 |
| Kolahi S et al. | Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. | 2010 | Clin. Biochem. | pmid:20034487 |
| Norazlina M et al. | Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine. | 2010 | Med. J. Malaysia | pmid:21265240 |
| Petri AD et al. | Effects of low-level laser therapy on human osteoblastic cells grown on titanium. | 2010 | Braz Dent J | pmid:21271038 |
| Zhang J et al. | [Effect of zoledronic acid on the differentiation and osteoprotegerin production of osteoblasts in rabbit]. | 2010 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:21122371 |
| Huang FM et al. | Platelet-rich fibrin increases proliferation and differentiation of human dental pulp cells. | 2010 | J Endod | pmid:20850666 |
| Breland UM et al. | Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease. | 2010 | Rheumatology (Oxford) | pmid:20231178 |
| Assmann G et al. | Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study. | 2010 | J. Rheumatol. | pmid:20231205 |
| Kenanidis EI et al. | Serum levels of bone turnover markers following total joint arthroplasty. | 2010 | J Orthop Surg (Hong Kong) | pmid:21187538 |
| Wang X et al. | [Association of serum follicle stimulating hormone with osteoprotegerin, leptin, TGF-β1, and TGF-β2 in women]. | 2010 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:21200095 |
| Pino AM et al. | Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. | 2010 | J. Bone Miner. Res. | pmid:19653807 |
| Masuki H et al. | Immunolocalization of DMP1 and sclerostin in the epiphyseal trabecule and diaphyseal cortical bone of osteoprotegerin deficient mice. | 2010 | Biomed. Res. | pmid:21079361 |
| Tawfeek H et al. | Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. | 2010 | PLoS ONE | pmid:20808842 |
| O'Sullivan EP et al. | Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes. | 2010 | Diabetes Metab. Res. Rev. | pmid:20809534 |
| Klika V and Marsik F | A thermodynamic model of bone remodelling: the influence of dynamic loading together with biochemical control. | 2010 | J Musculoskelet Neuronal Interact | pmid:20811146 |